Periodontal PocketPhase 2NCT06200415
Glucosamine Sulphate Versus Ginger in Non-Surgical Periodontal Therapy
A Phase 2 study testing Glucosamine Sulfate and Ginger Oil in people with Periodontal Pocket, run by Ain Shams University at 1 site in Egypt.
Trial summary
Glucosamine (GlcN) is an N-deacetyl amino monosaccharide sugar derived from complete hydrolysis of chitosan in which it is important vector for chondroitin and keratin sulfate, while on the other hand, medicinal plants became a source of great economic benefit worldwide, ginger has been found to have biological… Read more about this study
- Who is it for?
- Ages 25 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Periodontal Pocket
- What is being tested?
- Glucosamine Sulfate and Ginger Oil
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 8 Nov 2022to 8 Aug 2023
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Localized periodontitis, probing depth ≥5 mm. Less than 30% of teeth are involved.
- Age ranging from 25 to 50 years.
- Good compliance with the plaque control instructions following initial therapy.
- Availability for follow up and maintenance program.
- Systemically free according to the American Society of Anesthesiologists (ASA I).
Who cannot join
- Smokers
- Systemic diseases which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
- Pregnant and lactating females.
- Vulnerable groups of patients' e.g. (prisoners, handicapped patients and decision ally impaired individuals).
- Unwilling patients to perform oral hygiene measures of plaque control.
- Patients with a history of allergy against any components of the two materials.
- Previous Periodontal treatment or any use of antibiotic/anti-inflammatory drugs within the last 6 months before the initiation of the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Glucosamine Sulphate Versus Ginger as an Adjunctive Local Delivery Agents in Non-Surgical Periodontal Therapy (A Randomized Controlled Clinical Trial With Biochemical Analysis)
Glucosamine (GlcN) is an N-deacetyl amino monosaccharide sugar derived from complete hydrolysis of chitosan in which it is important vector for chondroitin and keratin sulfate, while on the other hand, medicinal plants became a source of great economic benefit worldwide, ginger has been found to have biological activities such as antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. So, these effects which made it a good candidate to be used in periodontal therapy. The main objective of this study is to assess and compare the effect of locally delivered glucosamine sulphate gel versus ginger gel on the clinical parameters in periodontitis patients including Plaque index (PI), Means sulcus bleeding index (MSBI), Probing depth (PD), Clinical attachment loss (CAL). and to detect the effect of locally delivered both gels on RANKL level in gingival crevicular fluid.
Read the detailed description
Periodontitis was described as a chronic multifactorial inflammatory disease associated with formation of plaque biofilms and characterized by progressive destruction of the tooth-supporting apparatus. Its primary manifestation includes the loss of periodontal tissue support, featured through clinical attachment loss (CAL) and radiographically alveolar bone loss with the presence of periodontal pockets which are a significant mark of the disease, hence, can progressively lead to tooth loss and gingival bleeding.
The new classification of periodontal and peri-implant diseases and conditions in 2017 classified these diseases into four main categories: First category concerned with periodontal health \& gingival diseases either dental biofilm induced gingivitis or non-dental biofilm induced gingivitis. Second category concerned with periodontitis which can be classified into necrotizing periodontitis, periodontitis as a manifestation of systemic disease and periodontitis which include the forms of the disease previously recognized as "chronic" or "aggressive". Third category concerned with other conditions can affect the periodontium as systemic diseases, traumatic occlusion, mucogingival deformities, tooth related factors, periodontal abscesses and endodontic-periodontal diseases. Fourth category concerned with peri-implant diseases and conditions as peri-implant health, peri-implant mucositis, peri-implantitis and peri-implant soft \& hard tissue deficiencies.
But now, Periodontitis can be described into four stages depending on the clinical attachment loss (CAL) starting from Stage 1: Initial periodontitis (CAL 1-2 mm), Stage 2: Moderate periodontitis (CAL 3-4 mm), Stage 3: Severe periodontitis with potential for additional tooth loss and Stage 4: Severe periodontitis with potential for loss of dentition (CAL ≥5 mm). Grading focuses on assessment of the risk factors as smoking, systemic factors as diabetes, and outcomes of non-surgical periodontal therapy. Grade A: Slow rate of progression (no CAL loss over 5 years), Grade B: Moderate rate of progression (CAL loss <2 mm over 5 years) and Grade C: Rapid rate of progression (≥2 mm over 5 years).
The pathogenesis of periodontal diseases is mediated by the inflammatory response to bacteria in the dental biofilm. The immune response to infection is regulated by cytokine and chemokine signals. Cytokines and chemokines (chemotactic cytokines) are the messages between cells. Cytokines are low-molecular-weight proteins involved in the initiation and advanced stages of inflammation, in which they can regulate the amplitude and the duration of the response. The genetic regulation leading to the secretion of proinflammatory cytokines from various cells is generally depending on the activation of nuclear factor kappa-B transcription. Cytokines are produced by resident cells, such as epithelial cells and fibroblasts, and by phagocytes (neutrophils and macrophages) in the acute and early chronic phases of inflammation, and by immune cells (lymphocytes) in early and advanced lesions. After recognition of the presented microbes to the appropriate cells, cytokines of the innate response, including tumor necrosis factor alpha, interleukin-1beta and interleukin-6, are the first to face in the pathogenesis pathways of the periodontal disease. It is suggested that individuals who produce high levels of these mediators in response to such thing will go through more and severe tissue loss.
In General, periodontitis is a chronic inflammation in which elimination of the virulent factors can be necessary in treatment of periodontitis by initial intervention by scaling and root surface debridement So, we should know about the importance of human gingival fibroblasts (HGFs). First, HGFs represent most prominent cells in periodontal tissue. Lipopolysaccharides (LPS)-treated HGFs produce inflammatory cytokines such as IL-6 and IL-8 and inflammatory chemical mediators such as Prostaglandin (PGE2), and second; HGFs continue to produce PGE2 IL-6, and IL-8 in the presence of LPS, unlike macrophages. So, it is known that large number of chemical mediators and cytokines was obtained from HGFs can be within the periodontal tissues. That kind of oral infection can be restricted by using antimicrobial mouth wash such as chlorhexidine. usual handling of these chemicals may induce unwanted adverse effects such as tooth staining, taste alteration and development of hypersensitivity reactions.
Antibiotics such as penicillin have been notified for dental caries prevention in humans and animals, merely they reported many side effects, added to the development of the bacterial resistance, so here comes the reason for a deep need for natural antibacterial substitutes. One of the strongest substitutes are medicinal plants.
Glucosamine is a biological element of joint cartilage, it has been known as popular systemic supplement combined with chondroitin sulfate for knee osteoarthritis (OA), as so these compounds could have a chondro-protective effect on knee OA. It is an amino monosaccharide in which it is important vector for chondroitin and keratin sulfate and also, an independent meta-analysis has shown that in trials using a particular formulation of glucosamine as the crystalline glucosamine sulfate (pCGS) gives better result on pain than other preparations of glucosamine did. Glucosamine has a role as a part of glucosaminoglycans (GAGs), it reveals an anti-inflammatory action in vitro and in vivo GlcN reduce the releasing of inflammatory mediators such as nitric oxide (NO), prostaglandin (PG) E2 and interleukin (IL)-8 by chondrocytes and synovial cells. These outcomes propose that GlcN expresses an anti-inflammatory effect on chondrocytes and synovial cells, hence revealing a protective action on OA. Chondroitin-sulphate (CS) and glycosamine-sulphate (GS) has proved a direct effect on OA in combination or alone, as CS has a direct effect on suppressing the production of osteoprotegerin OPG and RANKL the main two major factors involved in the remodeling process, and GS especially has a significant effect. In vitro studies have shown that glucosamine prevents bone resorption by means of down-regulation of RANKL expression in the joints, through lowering the number of RANKL positive T cells and the level of sRANKL in the joint's extracts.
On the other hand, medicinal plants became a source of great economic benefit worldwide. The recent natural recipes utilizing medicinal plants is giving a natural replacement for antibiotic unpleasant effects such as supra infections, hypersensitivity reaction and teeth staining. In addition, using of systemic antibiotics against oral infections is not recommended because of the risk for development of bacterial resistance. However, the discovery of natural extracts of medicinal plants with antimicrobial and anti-inflammatory activity will be valuable and safe.
Ginger (Zingiber officinale Roscoe), which belongs to the Zingiberaceae family and the Zingiber genus, has been commonly consumed as a spice and an herbal medicine for a long time. Bioactive compounds such as terpene and phenolic compounds have been recognized in ginger. The phenolic compounds are mainly gingerols, shogaol, and paradols, they resemble for different bioactivities of ginger. Ginger has been found to have biological activities such as antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. A lot of studies have revealed that ginger can affect many diseases, such as cardiovascular diseases, neurodegenerative diseases, obesity, diabetes mellitus, chemotherapy-induced nausea and emesis, and respiratory disorders. So, more attention will be focused on the bioactivities of the ginger.
In fresh ginger the major polyphenols are gingerols such as 6-gingerol, 8-gingerol, and 10-gingerol. Which if heat treated or stored for long time turns into into corresponding shogaol and after hydrogenation, shogaol can be transformed into paradols. It was found that overproduction of free radicals, such as reactive oxygen species (ROS), plays a strong role in the initiation of many chronic diseases.
Antioxidant activity: studies have shown that ginger has a protective effect against reactive oxygen species (ROS) as it showed antioxidant effects in the chondrocyte cells of human, with oxidative stress mediated by interleukin-1β (IL-1β). It lowers the production of ROS and lipid peroxidation and stimulates the expression of several antioxidant enzymes (). Ginger and its bioactive compounds (such as 6-shogaol) exerting an antioxidant role via the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway.
Anti-Inflammatory Activity: several studies has conveyed that ginger, and its active compounds has anti-inflammatory activity which can protect against inflammation-related diseases The anti-inflammatory effects were mostly related to phosphatidylinositiol -3-kinase (PI3K), protein kinase B (Akt), and the nuclear factor kappa light chain-enhancer of activated B cells (NF-κB). Adding that 6-shogaol exhibited a protective impact against tumor necrosis factor α (TNF-α). It also down regulates the Claudin-2 and the disassembly of Claudin-1 via the suppression of signaling pathways involved with PI3K/Akt and NF-κB. Moreover, nanoparticles derived from edible ginger (GDNPs 2) could increase the levels of anti-inflammatory cytokines such as interleukin-10 (IL-10) and IL-22 and decreasing the levels of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β specifically nanoparticles loaded with 6-shogaol so help in lowering the inflammatory process.
Cytotoxicity: Ginger has been examined and considered for its anticancer properties against different types of cancers, such as breast, cervical, prostate, and colorectal cancer Where its mechanisms of action are represented in the inhibition of proliferation and the induction of apoptosis in cancer cells.
Antidiabetic Activity: Diabetes mellitus is known as a serious metabolic disorder condition caused by insulin deficiency and/or insulin resistance, which results in an abnormal rising in blood glucose. Prolonged hyperglycemia could speed up the protein glycation production which results in formation of advanced glycation end products (AGEs). An in vitro study resulted in both 6-shogaol and 6-gingerol preventing the progression of diabetic complications, and how they prevent the production of AGEs by trapping methyl-glyoxal (MGO), the precursor of AGEs Other several studies have investigated the antidiabetic effect of ginger and its major active elements.
- Conditions
- Periodontal Pocket
- Being tested
- Glucosamine Sulfate, Ginger Oil
- Keywords
- glucosamine sulphate, ginger, local delivery
- Medical subject headings
- Periodontal Pocket
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Glucosamine SulfateDrug
Also called Glucosamine sulphate
Glucosamine sulphate (GLcN) is an N-deacetyl amino sugar derived from the complete hydrolysis of the chitosan with significant anti-inflammatory action.
Ginger OilDrug
Also called Ginger, Zingiber officinale, Zingiber genus
Ginger (Zingiber officinale Roscoe) has been found to have biological activities such as antioxidant, anti-inflammatory, antimicrobial, and anticancer activities.
| Study group | Role | What they receive |
|---|---|---|
| Glucosamine sulphate gel | Experimental | injecting about 2 mm of glucosamine sulphate gel in the affected periodontal pocket only once Receives: Drug: Glucosamine Sulfate |
| ginger gel | Experimental | injecting about 2 mm of ginger gel in the affected periodontal pocket only once Receives: Drug: Ginger Oil |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Plaque index PI in periodontitis patients
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Plaque index PI (0-3 score) in periodontitis patients
Measured: 1 month and three months
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Mean Sulcus Bleeding Index MSBI in periodontitis patients
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Mean Sulcus Bleeding Index MSBI (0-5 score) in periodontitis patients
Measured: 1 month and three months
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Probing depth PD in periodontitis patients
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Probing depth PD in millimeters in periodontitis patients
Measured: 1 month and three months
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on clinical attachment loss (cal) in periodontitis patients
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on clinical attachment loss (cal) in millimeters in periodontitis patients
Measured: 1 month and three months
Secondary outcomes (1)
2. Detect the effect of locally delivered glucosamine sulphate and ginger gels on receptor activator nuclear factor kappa B ligand (RANKL) level in gingival crevicular fluid
- Detect the effect of locally delivered glucosamine sulphate and ginger gels on receptor activator nuclear factor kappa B ligand (RANKL) level in g/ml in gingival crevicular fluid
Measured: 1 month and three months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jan 2024
- Study start8 Nov 2022
- Primary completion30 Jun 2023
- Study completion8 Aug 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Periodontal PocketStudies of the same condition, open and under way.
- More trials run by Ain Shams UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- supra and sub gingival scaling will be performed to all patients followed by application of local delivery drug within two groups to assess the effects after 1 month then 3 months.
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ain Shams University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rana Ali Mohamed Ali El-Gohary, Ain Shams University
- Investigators
- Hala A. Abuel Ela, professor, Study director, Faculty of dentistry- Ain Shams UniversityOlfat G. Shaker, professor, Study director, Cairo UniversityDina A. Othman, professor, Study director, Faculty of pharmacy- Azhar University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06200415
- Sponsor's protocol ID
- FDASU-Rec IM012013
- Status last verified
- Jan 2024
- First submitted
- 28 Dec 2023
- Last updated
- 17 Jan 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 17 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Glucosamine Sulphate Versus Ginger as an Adjunctive Local Delivery Agents in Non-Surgical Periodontal Therapy (A Randomized Controlled Clinical Trial With Biochemical Analysis)
- ClinicalTrials.gov ID
- NCT06200415
- Acronym / sponsor ID
- FDASU-Rec IM012013
- Conditions
- Periodontal Pocket
- Keywords
- glucosamine sulphate, ginger, local delivery
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Ain Shams UniversityUniversity, hospital or other
- Study start
- 8 Nov 2022 (actual)
- Primary completion
- 30 Jun 2023 (actual)
- Study completion
- 8 Aug 2023 (actual)
- First posted
- 11 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Glucosamine (GlcN) is an N-deacetyl amino monosaccharide sugar derived from complete hydrolysis of chitosan in which it is important vector for chondroitin and keratin sulfate, while on the other hand, medicinal plants became a source of great economic benefit worldwide, ginger has been found to have biological activities such as antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. So, these effects which made it a good candidate to be used in periodontal therapy. The main objective of this study is to assess and compare the effect of locally delivered glucosamine sulphate gel versus ginger gel on the clinical parameters in periodontitis patients including Plaque index (PI), Means sulcus bleeding index (MSBI), Probing depth (PD), Clinical attachment loss (CAL). and to detect the effect of locally delivered both gels on RANKL level in gingival crevicular fluid.
Detailed description
Periodontitis was described as a chronic multifactorial inflammatory disease associated with formation of plaque biofilms and characterized by progressive destruction of the tooth-supporting apparatus. Its primary manifestation includes the loss of periodontal tissue support, featured through clinical attachment loss (CAL) and radiographically alveolar bone loss with the presence of periodontal pockets which are a significant mark of the disease, hence, can progressively lead to tooth loss and gingival bleeding.
The new classification of periodontal and peri-implant diseases and conditions in 2017 classified these diseases into four main categories: First category concerned with periodontal health \& gingival diseases either dental biofilm induced gingivitis or non-dental biofilm induced gingivitis. Second category concerned with periodontitis which can be classified into necrotizing periodontitis, periodontitis as a manifestation of systemic disease and periodontitis which include the forms of the disease previously recognized as "chronic" or "aggressive". Third category concerned with other conditions can affect the periodontium as systemic diseases, traumatic occlusion, mucogingival deformities, tooth related factors, periodontal abscesses and endodontic-periodontal diseases. Fourth category concerned with peri-implant diseases and conditions as peri-implant health, peri-implant mucositis, peri-implantitis and peri-implant soft \& hard tissue deficiencies.
But now, Periodontitis can be described into four stages depending on the clinical attachment loss (CAL) starting from Stage 1: Initial periodontitis (CAL 1-2 mm), Stage 2: Moderate periodontitis (CAL 3-4 mm), Stage 3: Severe periodontitis with potential for additional tooth loss and Stage 4: Severe periodontitis with potential for loss of dentition (CAL ≥5 mm). Grading focuses on assessment of the risk factors as smoking, systemic factors as diabetes, and outcomes of non-surgical periodontal therapy. Grade A: Slow rate of progression (no CAL loss over 5 years), Grade B: Moderate rate of progression (CAL loss <2 mm over 5 years) and Grade C: Rapid rate of progression (≥2 mm over 5 years).
The pathogenesis of periodontal diseases is mediated by the inflammatory response to bacteria in the dental biofilm. The immune response to infection is regulated by cytokine and chemokine signals. Cytokines and chemokines (chemotactic cytokines) are the messages between cells. Cytokines are low-molecular-weight proteins involved in the initiation and advanced stages of inflammation, in which they can regulate the amplitude and the duration of the response. The genetic regulation leading to the secretion of proinflammatory cytokines from various cells is generally depending on the activation of nuclear factor kappa-B transcription. Cytokines are produced by resident cells, such as epithelial cells and fibroblasts, and by phagocytes (neutrophils and macrophages) in the acute and early chronic phases of inflammation, and by immune cells (lymphocytes) in early and advanced lesions. After recognition of the presented microbes to the appropriate cells, cytokines of the innate response, including tumor necrosis factor alpha, interleukin-1beta and interleukin-6, are the first to face in the pathogenesis pathways of the periodontal disease. It is suggested that individuals who produce high levels of these mediators in response to such thing will go through more and severe tissue loss.
In General, periodontitis is a chronic inflammation in which elimination of the virulent factors can be necessary in treatment of periodontitis by initial intervention by scaling and root surface debridement So, we should know about the importance of human gingival fibroblasts (HGFs). First, HGFs represent most prominent cells in periodontal tissue. Lipopolysaccharides (LPS)-treated HGFs produce inflammatory cytokines such as IL-6 and IL-8 and inflammatory chemical mediators such as Prostaglandin (PGE2), and second; HGFs continue to produce PGE2 IL-6, and IL-8 in the presence of LPS, unlike macrophages. So, it is known that large number of chemical mediators and cytokines was obtained from HGFs can be within the periodontal tissues. That kind of oral infection can be restricted by using antimicrobial mouth wash such as chlorhexidine. usual handling of these chemicals may induce unwanted adverse effects such as tooth staining, taste alteration and development of hypersensitivity reactions.
Antibiotics such as penicillin have been notified for dental caries prevention in humans and animals, merely they reported many side effects, added to the development of the bacterial resistance, so here comes the reason for a deep need for natural antibacterial substitutes. One of the strongest substitutes are medicinal plants.
Glucosamine is a biological element of joint cartilage, it has been known as popular systemic supplement combined with chondroitin sulfate for knee osteoarthritis (OA), as so these compounds could have a chondro-protective effect on knee OA. It is an amino monosaccharide in which it is important vector for chondroitin and keratin sulfate and also, an independent meta-analysis has shown that in trials using a particular formulation of glucosamine as the crystalline glucosamine sulfate (pCGS) gives better result on pain than other preparations of glucosamine did. Glucosamine has a role as a part of glucosaminoglycans (GAGs), it reveals an anti-inflammatory action in vitro and in vivo GlcN reduce the releasing of inflammatory mediators such as nitric oxide (NO), prostaglandin (PG) E2 and interleukin (IL)-8 by chondrocytes and synovial cells. These outcomes propose that GlcN expresses an anti-inflammatory effect on chondrocytes and synovial cells, hence revealing a protective action on OA. Chondroitin-sulphate (CS) and glycosamine-sulphate (GS) has proved a direct effect on OA in combination or alone, as CS has a direct effect on suppressing the production of osteoprotegerin OPG and RANKL the main two major factors involved in the remodeling process, and GS especially has a significant effect. In vitro studies have shown that glucosamine prevents bone resorption by means of down-regulation of RANKL expression in the joints, through lowering the number of RANKL positive T cells and the level of sRANKL in the joint's extracts.
On the other hand, medicinal plants became a source of great economic benefit worldwide. The recent natural recipes utilizing medicinal plants is giving a natural replacement for antibiotic unpleasant effects such as supra infections, hypersensitivity reaction and teeth staining. In addition, using of systemic antibiotics against oral infections is not recommended because of the risk for development of bacterial resistance. However, the discovery of natural extracts of medicinal plants with antimicrobial and anti-inflammatory activity will be valuable and safe.
Ginger (Zingiber officinale Roscoe), which belongs to the Zingiberaceae family and the Zingiber genus, has been commonly consumed as a spice and an herbal medicine for a long time. Bioactive compounds such as terpene and phenolic compounds have been recognized in ginger. The phenolic compounds are mainly gingerols, shogaol, and paradols, they resemble for different bioactivities of ginger. Ginger has been found to have biological activities such as antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. A lot of studies have revealed that ginger can affect many diseases, such as cardiovascular diseases, neurodegenerative diseases, obesity, diabetes mellitus, chemotherapy-induced nausea and emesis, and respiratory disorders. So, more attention will be focused on the bioactivities of the ginger.
In fresh ginger the major polyphenols are gingerols such as 6-gingerol, 8-gingerol, and 10-gingerol. Which if heat treated or stored for long time turns into into corresponding shogaol and after hydrogenation, shogaol can be transformed into paradols. It was found that overproduction of free radicals, such as reactive oxygen species (ROS), plays a strong role in the initiation of many chronic diseases.
Antioxidant activity: studies have shown that ginger has a protective effect against reactive oxygen species (ROS) as it showed antioxidant effects in the chondrocyte cells of human, with oxidative stress mediated by interleukin-1β (IL-1β). It lowers the production of ROS and lipid peroxidation and stimulates the expression of several antioxidant enzymes (). Ginger and its bioactive compounds (such as 6-shogaol) exerting an antioxidant role via the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway.
Anti-Inflammatory Activity: several studies has conveyed that ginger, and its active compounds has anti-inflammatory activity which can protect against inflammation-related diseases The anti-inflammatory effects were mostly related to phosphatidylinositiol -3-kinase (PI3K), protein kinase B (Akt), and the nuclear factor kappa light chain-enhancer of activated B cells (NF-κB). Adding that 6-shogaol exhibited a protective impact against tumor necrosis factor α (TNF-α). It also down regulates the Claudin-2 and the disassembly of Claudin-1 via the suppression of signaling pathways involved with PI3K/Akt and NF-κB. Moreover, nanoparticles derived from edible ginger (GDNPs 2) could increase the levels of anti-inflammatory cytokines such as interleukin-10 (IL-10) and IL-22 and decreasing the levels of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β specifically nanoparticles loaded with 6-shogaol so help in lowering the inflammatory process.
Cytotoxicity: Ginger has been examined and considered for its anticancer properties against different types of cancers, such as breast, cervical, prostate, and colorectal cancer Where its mechanisms of action are represented in the inhibition of proliferation and the induction of apoptosis in cancer cells.
Antidiabetic Activity: Diabetes mellitus is known as a serious metabolic disorder condition caused by insulin deficiency and/or insulin resistance, which results in an abnormal rising in blood glucose. Prolonged hyperglycemia could speed up the protein glycation production which results in formation of advanced glycation end products (AGEs). An in vitro study resulted in both 6-shogaol and 6-gingerol preventing the progression of diabetic complications, and how they prevent the production of AGEs by trapping methyl-glyoxal (MGO), the precursor of AGEs Other several studies have investigated the antidiabetic effect of ginger and its major active elements.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- supra and sub gingival scaling will be performed to all patients followed by application of local delivery drug within two groups to assess the effects after 1 month then 3 months.
| Arm | Type | Receives |
|---|---|---|
| Glucosamine sulphate gel | Experimental | Drug: Glucosamine Sulfateinjecting about 2 mm of glucosamine sulphate gel in the affected periodontal pocket only once |
| ginger gel | Experimental | Drug: Ginger Oilinjecting about 2 mm of ginger gel in the affected periodontal pocket only once |
Who may qualify
- Ages
- 25 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Localized periodontitis, probing depth ≥5 mm. Less than 30% of teeth are involved.
- Age ranging from 25 to 50 years.
- Good compliance with the plaque control instructions following initial therapy.
- Availability for follow up and maintenance program.
- Systemically free according to the American Society of Anesthesiologists (ASA I).
Key exclusion criteria (7 listed)
- Smokers
- Systemic diseases which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire).
- Pregnant and lactating females.
- Vulnerable groups of patients' e.g. (prisoners, handicapped patients and decision ally impaired individuals).
- Unwilling patients to perform oral hygiene measures of plaque control.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Glucosamine SulfateAlso: Glucosamine sulphateGlucosamine sulphate (GLcN) is an N-deacetyl amino sugar derived from the complete hydrolysis of the chitosan with significant anti-inflammatory action. | Drug | Glucosamine sulphate gel |
| Ginger OilAlso: Ginger, Zingiber officinale, Zingiber genusGinger (Zingiber officinale Roscoe) has been found to have biological activities such as antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. | Drug | ginger gel |
Primary outcome
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Plaque index PI in periodontitis patients
Time frame: 1 month and three months
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Plaque index PI (0-3 score) in periodontitis patients
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Mean Sulcus Bleeding Index MSBI in periodontitis patients
Time frame: 1 month and three months
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Mean Sulcus Bleeding Index MSBI (0-5 score) in periodontitis patients
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Probing depth PD in periodontitis patients
Time frame: 1 month and three months
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Probing depth PD in millimeters in periodontitis patients
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on clinical attachment loss (cal) in periodontitis patients
Time frame: 1 month and three months
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on clinical attachment loss (cal) in millimeters in periodontitis patients
1 secondary outcome
2. Detect the effect of locally delivered glucosamine sulphate and ginger gels on receptor activator nuclear factor kappa B ligand (RANKL) level in gingival crevicular fluid
Time frame: 1 month and three months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jan 2024.
- Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trialLink provided by the sponsor.
- Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science studyLink provided by the sponsor.
- Gingerdione A, a polyphenol present in ginger, suppresses obesity and adipose tissue inflammation in high-fat diet-fed miceLink provided by the sponsor.
- 6-Paradol and 6-Shogaol, the Pungent Compounds of Ginger, Promote Glucose Utilization in Adipocytes and Myotubes, and 6-Paradol Reduces Blood Glucose in High-Fat Diet-Fed MiceLink provided by the sponsor.
- Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for Periodontal Pocket
Recruiting
A Closed Surgical Technique vs Modified Papilla Preservation Technique
Intrabony Periodontal Defect, Treatment
RecruitingObservational study
Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years
Diabete Mellitus, Dyslipidaemia
Not yet recruitingPhase 2
Effect of Gingival Mesenchymal Stem Cell-Derived Small Extracellular Vesicles in Management of Infra-bony Periodontal Defect
Infra-bony Periodontal Defect
Not yet recruiting
Diode Laser 635 nm and 810 nm Photodynamic Therapy as Adjuncts to Non-Surgical Periodontal Treatment
Periodontitis
Not yet recruiting
Clinical Effectiveness of Oxygen-Releasing Oral Gel as an Adjunct to Scaling and Root Debridement in Patients With Severe Periodontal Pockets: A Randomized Clinical Trial
Periodontitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hala A. Abuel Ela, professor study director
Faculty of dentistry- Ain Shams University
Olfat G. Shaker, professor study director
Cairo University
Dina A. Othman, professor study director
Faculty of pharmacy- Azhar University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Glucosamine Sulfate and Ginger Oil in people with Periodontal Pocket, run by Ain Shams University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assess the effect of locally delivered glucosamine sulphate gel versus ginger gel on Plaque index PI in periodontitis patients (time frame: 1 month and three months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2024.